Summary

The suppository packaging market is projected to reach USD 428 million by 2029, at a CAGR of 6.5% from USD 312 million in 2024. The demand for suppository packaging arises from their versatile applications and advantageous properties across various industries. These polymers, produced through emulsion polymerization, consist of polymer particles dispersed in water. Additionally, suppository packaging find extensive use in textiles for enhancing fabric strength, flexibility, and resistance to washing. In the paper industry, they improve coating properties, printability, and surface finish. Moreover, suppository packaging are utilized in carpet backing, nonwoven fabrics, and specialty latex products, further expanding their application scope. As industries continue to seek cost-effective and environmentally friendly solutions, the demand for suppository packaging is expected to grow. Their low volatile organic compound (VOC) emissions and compliance with stringent environmental regulations make them increasingly attractive.
“Based on material, aluminum/PE is expected to be the fastest growing market during the forecast period, in terms of value.”
Aluminum/PE is the fastest growing segments in the suppository packaging market due to their unique combination of properties and diverse applications. The aluminum part gives a remarkable obstruction to dampness, light, and oxygen, which assists with safeguarding the solidarity and viability of the suppository substance. Maintaining the quality and performance of temperature-sensitive medicines over time is crucial, and the aluminum layer plays a key role in extending product shelf life. A packing material that is both pleasantly flexible and durable is created when polyethylene and tailored aluminum film are combined. It ensures that the product remains whole and ready for use as intended by allowing customers to tear open the packaging without damaging the suppository itself.
“Based on application, urethral is the fastest growing market during the forecast period, in terms of value.”
The urethral application is the fastest-growing segment in the suppository packaging market. In particular, the benefits associated with urethral drug delivery for diseases like erectile dysfunction and urinary tract infection, in which local treatment could help rapidly to offer relief and improve patient outcome, have been realized more and more. This mode of administration allows for a direct absorption via the mucous membranes and avoids the gastrointestinal tract and first-pass metabolism, which enhances the drug effectiveness. Moreover, the increasing number of conditions requiring the treatment of urinary tract infections, as well as the growing population, is driving demand for these specialty medications as healthcare providers seek more effective treatments for patients who may find it difficult for oral medications, liquid tablets are gaining traction as viable options.
“Based on region, Asia Pacific is the fastest growing market for suppository packaging in 2023, in terms of value.”
The demand for suppository packaging in Asia-Pacific is driven by several key factors. With the expansion of healthcare in this sector, hospitals, clinics and pharmaceuticals, the need for specialized drug delivery systems including suppositories increases. The increasing incidence of cancer, diabetes and gastrointestinal disorders requires new methods of drug delivery to the elderly population. As older adults typically implants are preferred or needed because of difficulty in swallowing implants or the need for local treatment. Furthermore, increased health literacy and implants acknowledging the efficacy of treatment drives the growth of the suppository packaging market in the region.
In the process of determining and verifying the market size for several segments and subsegments identified through secondary research, extensive primary interviews were conducted. A breakdown of the profiles of the primary interviewees are as follows:
• By Company Type: Tier 1 - 35%, Tier 2 - 45%, and Tier 3 - 20%
• By Designation: C-Level - 35%, Director Level - 25%, and Others - 40%
• By Region: North America - 30%, Europe - 20%, Asia Pacific - 40%, Middle East & Africa-5%, and Latin America-5%
The key players in this market are NextPharma Technologies (UK), CordenPharma (Switzerland), Recipharm AB (Sweden), Valmatic S.R.L. (Italy), Sarong S.p.A. (Italy), Key International (US), HySum Europe GmbH (Germany), FAMAR Health Care Services (Greece), Hudi Pharma HQ (Italy), Adragos Pharma (Germany), LGM Pharma (US), Aluberg s.p.a. (Italy), Delpharm (France), Unither (France), and Trefoil Packaging Pvt Ltd (India).
Research Coverage
This report segments the suppository packaging market based on material, application, and region, and provides estimations for the overall value of the market across various regions. A detailed analysis of key industry players has been conducted to provide insights into their business overviews, products and services, key strategies, new product launches, expansions, and mergers and acquisitions associated with the suppository packaging market.
Key benefits of buying this report
This research report focuses on various levels of analysis, including industry analysis (industry trends), market ranking analysis of top players, and company profiles, which together provide an overall view of the competitive landscape, emerging and high-growth segments of the suppository packaging market, high-growth regions, and market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
• Analysis of key drivers (growing geriatric population, increasing demand for child-resistant packaging, increased focus on patient convenience, rising prevalence of chronic diseases), restraints (adhering to regulatory standards, growing development in technologies), opportunities (growing demand for sustainable and environmentally friendly packaging solutions, rising awareness of health and safety) and challenges (storage and handling requirements).
• Market Penetration: Comprehensive information on the suppository packaging market offered by top players in the global suppository packaging market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the suppository packaging market.
• Market Development: Comprehensive information about lucrative emerging markets — the report analyzes the markets for suppository packaging market across regions.
• Market Diversification: Exhaustive information about new products, untapped regions, and recent developments in the global suppository packaging market
• Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the suppository packaging market

ページTOPに戻る

Table of Contents

1 INTRODUCTION 24
1.1 STUDY OBJECTIVES 24
1.2 MARKET DEFINITION 24
1.3 STUDY SCOPE 25
1.3.1 MARKETS COVERED 25
1.3.2 INCLUSIONS AND EXCLUSIONS 26
1.3.3 YEARS CONSIDERED 26
1.3.4 CURRENCY CONSIDERED 27
1.3.5 UNITS CONSIDERED 27
1.4 LIMITATIONS 27
1.5 STAKEHOLDERS 27
1.6 SUMMARY OF CHANGES 28
2 RESEARCH METHODOLOGY 29
2.1 RESEARCH DATA 29
2.1.1 SECONDARY DATA 30
2.1.1.1 Key data from secondary sources 30
2.1.2 PRIMARY DATA 31
2.1.2.1 Key data from primary sources 31
2.1.2.2 Breakdown of primaries 32
2.2 MARKET SIZE ESTIMATION 32
2.3 DATA TRIANGULATION 34
2.4 FACTOR ANALYSIS 35
2.5 RESEARCH ASSUMPTIONS 35
2.6 RESEARCH LIMITATIONS 35
2.7 RISK ASSESSMENT 36
3 EXECUTIVE SUMMARY 37
4 PREMIUM INSIGHTS 40
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN SUPPOSITORY PACKAGING MARKET 40
4.2 SUPPOSITORY PACKAGING MARKET, BY MATERIAL 40
4.3 SUPPOSITORY PACKAGING MARKET, BY APPLICATION 41
4.4 NORTH AMERICA: SUPPOSITORY PACKAGING MARKET, BY MATERIAL AND COUNTRY 41
4.5 SUPPOSITORY PACKAGING MARKET, BY COUNTRY 42
 
5 MARKET OVERVIEW 43
5.1 INTRODUCTION 43
5.2 MARKET DYNAMICS 44
5.2.1 DRIVERS 44
5.2.1.1 Global increase in aging population and incidence of
chronic diseases 44
5.2.1.2 Rise in healthcare expenditure 46
5.2.1.3 Rising recognition of suppository benefits 47
5.2.2 RESTRAINTS 48
5.2.2.1 Rigorous regulatory compliance 48
5.2.3 OPPORTUNITIES 48
5.2.3.1 Ongoing technological developments 48
5.2.3.2 Increasing demand from emerging markets 49
5.2.4 CHALLENGES 50
5.2.4.1 High cost of advanced packaging solutions 50
5.2.4.2 Limited shelf life 50
6 INDUSTRY TRENDS 52
6.1 PORTER’S FIVE FORCES ANALYSIS 52
6.1.1 BARGAINING POWER OF SUPPLIERS 53
6.1.2 BARGAINING POWER OF BUYERS 53
6.1.3 INTENSITY OF COMPETITIVE RIVALRY 53
6.1.4 THREAT OF NEW ENTRANTS 53
6.1.5 THREAT OF SUBSTITUTES 53
6.2 KEY STAKEHOLDERS & BUYING CRITERIA 54
6.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 54
6.2.2 BUYING CRITERIA 54
6.3 VALUE CHAIN ANALYSIS 56
6.4 ECOSYSTEM ANALYSIS 56
6.5 TRADE ANALYSIS 58
6.5.1 EXPORT SCENARIO OF SUPPOSITORY PACKAGING 58
6.5.2 IMPORT SCENARIO OF SUPPOSITORY PACKAGING 59
6.6 TECHNOLOGY ANALYSIS 60
6.6.1 KEY TECHNOLOGIES 60
6.6.1.1 Blister packaging technology 60
6.6.1.2 Strip packaging technology 60
6.6.1.3 Form-Fill-Seal (FFS) machine technology 61
6.6.1.4 Injection molding technology 61
6.6.2 COMPLEMENTARY TECHNOLOGIES 61
6.6.2.1 Smart packaging technology 61
6.6.2.2 Cold chain management technology 62
6.7 IMPACT OF GEN AI ON SUPPOSITORY PACKAGING MARKET 62
6.8 REGULATORY LANDSCAPE 63
6.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 63
6.9 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 66
6.10 PRICING ANALYSIS 67
6.10.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY MATERIAL 67
6.10.2 AVERAGE SELLING PRICE TREND OF SUPPOSITORY PACKAGING, BY REGION 68
6.11 PATENT ANALYSIS 69
6.11.1 METHODOLOGY 69
6.11.2 MAJOR PATENTS 69
6.12 KEY CONFERENCES AND EVENTS, 2024–2025 73
6.13 MACROECONOMIC ANALYSIS 73
6.13.1 INTRODUCTION 73
7 SUPPOSITORY PACKAGING MARKET, BY MATERIAL 75
7.1 INTRODUCTION 76
7.2 ALUMINUM/PE 77
7.2.1 EXCELLENT MOISTURE RESISTANCE AND LIGHT-BLOCKING
PROPERTIES TO DRIVE DEMAND 77
7.3 PVC/PE 78
7.3.1 THERMOFORMABLE PROPERTIES AND ABILITY TO PREVENT LEAKAGE OR CONTAMINATION OF SUPPOSITORIES TO FUEL DEMAND 78
7.4 OTHER MATERIALS 78
8 SUPPOSITORY PACKAGING MARKET, BY APPLICATION 79
8.1 INTRODUCTION 80
8.2 PHARMACEUTICALS 81
8.2.1 GROWING USE TO ENSURE SAFE, EFFECTIVE, AND INFORMED DELIVERY OF SUPPOSITORY MEDICATIONS TO PATIENTS TO DRIVE MARKET 81
8.2.2 NASAL SUPPOSITORY PACKAGING 82
8.2.3 EAR SUPPOSITORY PACKAGING 82
8.2.4 RECTAL SUPPOSITORY PACKAGING 82
8.2.5 URETHRAL SUPPOSITORY PACKAGING 83
8.2.6 VAGINAL SUPPOSITORY PACKAGING 83
8.2.7 OTHER APPLICATIONS 83
9 SUPPOSITORY PACKAGING MARKET, BY REGION 84
9.1 INTRODUCTION 85
9.2 NORTH AMERICA 86
9.2.1 US 91
9.2.1.1 Increasing number of pediatric patients to drive market 91
9.2.2 CANADA 93
9.2.2.1 Government-led initiatives to promote safe drug packaging
to fuel demand 93
9.2.3 MEXICO 95
9.2.3.1 Strategic shift of global pharmaceutical companies toward Mexico to drive market 95
9.3 EUROPE 97
9.3.1 GERMANY 102
9.3.1.1 Rising emphasis on prevention and self-medication to drive market 102
9.3.2 FRANCE 104
9.3.2.1 Increasing healthcare expenditure and health consciousness to
drive market 104
9.3.3 UK 106
9.3.3.1 Rising focus on patient-centric care to drive market 106
9.3.4 ITALY 107
9.3.4.1 Technological advancements in pharmaceutical manufacturing processes to drive market 107
9.3.5 SPAIN 109
9.3.5.1 Increasing demand for minimally invasive drug delivery systems to drive market 109
9.3.6 REST OF EUROPE 111
9.4 ASIA PACIFIC 112
9.4.1 CHINA 116
9.4.1.1 Rapidly aging population and increasing healthcare expenditures to drive market 116
9.4.2 INDIA 118
9.4.2.1 Expanding pharmaceutical industry to drive market 118
9.4.3 JAPAN 120
9.4.3.1 Need for convenient and reliable pharmaceutical packaging solutions to drive market 120
9.4.4 AUSTRALIA 121
9.4.4.1 Government-led initiative for safe pharmaceutical drugs production and consumption to drive market 121
9.4.5 REST OF ASIA PACIFIC 123
9.5 SOUTH AMERICA 125
9.5.1 BRAZIL 129
9.5.1.1 High adoption in pharmaceutical industry to drive market 129
9.5.2 ARGENTINA 130
9.5.2.1 Trend of enhancing packaging technologies to fuel market growth 130
9.5.3 REST OF SOUTH AMERICA 132
9.6 MIDDLE EAST & AFRICA 134
9.6.1 GCC COUNTRIES 139
9.6.1.1 Saudi Arabia 140
9.6.1.1.1 Rapidly expanding population and increased
investments by foreign companies in pharmaceutical industry to drive market 140
 
9.6.1.2 UAE 142
9.6.1.2.1 Increasing demand for high-value pharmaceutical products to drive market 142
9.6.2 REST OF GCC COUNTRIES 144
9.6.3 TURKEY 146
9.6.3.1 Advantages of suppository packaging over traditional oral medications to drive demand 146
9.6.4 REST OF MIDDLE EAST & AFRICA 147
10 COMPETITIVE LANDSCAPE 150
10.1 OVERVIEW 150
10.1.1 KEY STRATEGIES/RIGHT TO WIN, 2022–2024 150
10.1.2 REVENUE ANALYSIS, 2018–2023 151
10.1.3 MARKET SHARE ANALYSIS, 2023 152
10.1.4 INDUSTRY STRUCTURE 152
10.1.4.1 CordenPharma 153
10.1.4.2 HySum Europe GmbH 153
10.1.4.3 ACG 153
10.1.4.4 KAA Timex LR 153
10.1.4.5 Aluberg S.P.A. 153
10.1.5 COMPANY VALUATION AND FINANCIAL METRICS 154
10.1.6 BRAND/PRODUCT COMPARISON 155
10.2 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 155
10.2.1 STARS 155
10.2.2 EMERGING LEADERS 155
10.2.3 PERVASIVE PLAYERS 156
10.2.4 PARTICIPANTS 156
10.2.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 157
10.2.5.1 Company footprint 157
10.2.5.2 Material footprint 157
10.2.5.3 Application footprint 158
10.2.5.4 Region footprint 158
10.3 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 159
10.3.1 PROGRESSIVE COMPANIES 159
10.3.2 RESPONSIVE COMPANIES 159
10.3.3 DYNAMIC COMPANIES 159
10.3.4 STARTING BLOCKS 159
10.3.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 161
10.3.5.1 List of key startups/SMEs 161
10.3.5.2 Competitive benchmarking of key startups/SMEs 162
 
10.4 COMPETITIVE SCENARIO 164
10.4.1 DEALS 164
10.4.2 EXPANSIONS 165
11 COMPANY PROFILES 166
11.1 KEY PLAYERS 166
11.1.1 CONSTANTIA FLEXIBLES 166
11.1.1.1 Business overview 166
11.1.1.2 Products/Solutions/Services offered 166
11.1.1.3 Recent developments 167
11.1.1.3.1 Deals 167
11.1.1.3.2 Expansions 167
11.1.1.4 MnM view 168
11.1.1.4.1 Key strengths/Right to win 168
11.1.1.4.2 Strategic choices 168
11.1.1.4.3 Weaknesses/Competitive threats 168
11.1.2 DELPHARM 169
11.1.2.1 Business overview 169
11.1.2.2 Products/Solutions/Services offered 169
11.1.2.3 Recent developments 170
11.1.2.3.1 Deals 170
11.1.2.4 MnM view 170
11.1.2.4.1 Key strengths/Right to win 170
11.1.2.4.2 Strategic choices 170
11.1.2.4.3 Weaknesses/Competitive threats 170
11.1.3 CORDENPHARMA 171
11.1.3.1 Business overview 171
11.1.3.2 Products/Solutions/Services offered 171
11.1.3.3 Recent developments 171
11.1.3.3.1 Deals 171
11.1.3.4 MnM view 172
11.1.3.4.1 Key strengths/Right to win 172
11.1.3.4.2 Strategic choices 172
11.1.3.4.3 Weaknesses/Competitive threats 172
11.1.4 AENOVA GROUP 173
11.1.4.1 Business overview 173
11.1.4.2 Products/Solutions/Services offered 174
11.1.4.3 Recent developments 174
11.1.4.3.1 Deals 174
11.1.4.4 MnM view 174
11.1.4.4.1 Key strengths/Right to win 174
11.1.4.4.2 Strategic choices 174
11.1.4.4.3 Weaknesses/Competitive threats 175
11.1.5 UNITHER PHARMACEUTICAL 176
11.1.5.1 Business overview 176
11.1.5.2 Products/Solutions/Services offered 176
11.1.5.3 MnM view 176
11.1.5.3.1 Key strengths/Right to win 176
11.1.5.3.2 Strategic choices 177
11.1.5.3.3 Weaknesses/Competitive threats 177
11.1.6 ACG 178
11.1.6.1 Business overview 178
11.1.6.2 Products/Solutions/Services offered 178
11.1.6.3 Recent developments 179
11.1.6.3.1 Deals 179
11.1.6.4 MnM view 179
11.1.7 HYSUM EUROPE GMBH 180
11.1.7.1 Business overview 180
11.1.7.2 Products/Solutions/Services offered 180
11.1.7.3 MnM view 180
11.1.8 CAPRIHANS INDIA LIMITED. 181
11.1.8.1 Business overview 181
11.1.8.2 Products/Solutions/Services offered 182
11.1.8.3 MnM view 182
11.1.9 FENGCHEN GROUP CO., LTD 183
11.1.9.1 Business overview 183
11.1.9.2 Products/Solutions/Services offered 183
11.1.9.3 MnM view 184
11.1.10 KAA TIMEX LR 185
11.1.10.1 Business overview 185
11.1.10.2 Products/Solutions/Services offered 185
11.1.10.3 MnM view 185
11.2 OTHER PLAYERS 186
11.2.1 ALUBERG S.P.A. 186
11.2.2 FAMAR HEALTH CARE SERVICES 187
11.2.3 LGM PHARMA. 188
11.2.4 SARONG S.P.A. 189
11.2.5 ADRAGOS PHARMA. 189
11.2.6 VALMATIC S.R.L. 190
11.2.7 HUDI PHARMA 191
11.2.8 NEXTPHARMA TECHNOLOGIES 192
11.2.9 TREFOIL PACKAGING PVT LTD 193
 
11.2.10 SGM INDIA 194
11.2.11 GREEN PACK FOILS PVT. LTD. 195
11.2.12 BERKO PHARMACEUTICALS 196
12 ADJACENT AND RELATED MARKET 197
12.1 INTRODUCTION 197
12.2 LIMITATIONS 197
12.2.1 PHARMACEUTICAL PACKAGING MARKET 197
12.2.1.1 Market definition 197
12.2.1.2 Pharmaceutical packaging market, by packaging type 198
12.2.1.3 Pharmaceutical packaging market, by raw material 198
12.2.1.4 Pharmaceutical packaging market, by drug delivery 200
12.2.1.5 Pharmaceutical packaging market, by type 201
12.2.1.6 Pharmaceutical packaging market, by region 203
12.2.2 HEALTH AND HYGIENE PACKAGING MARKET 204
12.2.2.1 Market definition 204
12.2.2.2 Health and hygiene packaging market, by type 204
12.2.2.3 Health and hygiene packaging market, by form 207
12.2.2.4 Health and hygiene packaging market, by shipping form 208
12.2.2.5 Health and hygiene packaging market, by structure 210
12.2.2.6 Health and hygiene packaging market, by distribution channel 211
12.2.2.7 Health and hygiene packaging market, by end-use industry 212
12.2.2.8 Health and hygiene packaging market, by region 214
13 APPENDIX 216
13.1 DISCUSSION GUIDE 216
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 219
13.3 CUSTOMIZATION OPTIONS 221
13.4 RELATED REPORTS 221
13.5 AUTHOR DETAILS 222